Kyverna Therapeutics Inc.
KYTX | NASDAQ
$7.32
+$0.20 (+2.81%)
Sep 22, 2026, 12:19 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PE Ratio | -3.03 | -2.63 | -2.58 | -1.61 | -0.84 | -0.57 | -1.08 | -1.59 | -2.97 | -9.96 | -19.11 | -23.26 | -32.26 | -47.62 | -172.94Qu |
PEG Ratio | 0.67 | 0.15 | 0.44 | 0.13 | 0.14 | -0.03 | -0.12 | -0.08 | 0.07 | -0.07 | -0.57 | -1.16 | 1.07 | -0.41 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.59K |
PB Ratio | 3.28 | 2.67 | 1.91 | 1.71 | 0.72 | 0.37 | 0.61 | 0.70 | 1.01 | 1.48 | 26.30 | 18.81 | 3.58 | n/a | n/a |
P/FCF Ratio | -3.40 | -3.45 | -2.87 | -1.64 | -0.93 | -0.62 | -1.39 | -2.16 | -4.13 | -7.91 | -24.39 | -37.89 | -56.87 | -67.40 | n/a |
P/OCF Ratio | -3.42 | -3.47 | -2.88 | -1.66 | -0.94 | -0.62 | -1.41 | -2.20 | -4.24 | -8.05 | -24.68 | -38.21 | -56.94 | -67.56 | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.05 | 0.17 | 0.12 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.18 | 0.14 | 0.03 | n/a | n/a |
Quick Ratio | 9.06 | 8.15 | 7.75 | 5.16 | 5.39 | 7.44 | 8.61 | 10.50 | 14.86 | 17.17 | 3.05 | 4.71 | 17.17 | n/a | n/a |
Current Ratio | 9.06 | 8.15 | 7.75 | 5.16 | 5.39 | 7.44 | 8.61 | 10.50 | 14.86 | 17.17 | 3.05 | 4.71 | 17.17 | n/a | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -58.69 | -62.02 | -88.47 | -5.53K | -3.17K | -1.9K | -1.52K | -1.21K | -857.31 | -0.67 | -454.83 | -325.64 | -289.17 | -260.11 | -214.02 |
Return on Equity | -23.15% | -20.31% | -16.28% | -24.21% | -22.82% | -19.93% | -14.06% | -11.39% | -8.64% | -0.01% | -42.03% | -22.49% | -3.63% | n/a | n/a |
Return on Assets | -17.43% | -15.46% | -12.87% | -19.66% | -18.58% | -17.12% | -12.31% | -10.17% | -7.93% | -0.01% | -27.48% | -16.72% | -3.36% | n/a | n/a |
Return on Invested Capital | -19.92% | -18.04% | -15.03% | -24.67% | -23.34% | -20.53% | -14.83% | -12.42% | -9.73% | -0.01% | -36.69% | -20.77% | -3.58% | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -32.62% |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.01K% |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.01K% |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.11K% |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.87K% |
Add to Watchlist
Select watchlists to add or remove KYTX